Panic attack in Temovate e - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Panic attack, when it was recovered, drug effectiveness, race, and more among people who take Temovate e (clobetasol propionate). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Temovate e?

Temovate e has active ingredients of clobetasol propionate. eHealthMe is studying from 16 Temovate e users. Check the latest studies of Temovate e.

What is Panic attack?

Panic attack is found to be associated with 2,292 drugs and 2,081 conditions by eHealthMe. Check the latest studies of Panic attack.

On Jun, 27, 2026

1 person who has Panic attack while taking Temovate e was studied.

Severity of Panic attack *:

least: 0.0 %
moderate: 0.0 %
severe: 100 %
most severe: 0.0 %

When people recovered from Panic attack *:

while on drug: 0.0 %
after off the drug: 0.0 %
not yet: 100 %

Effectiveness of Temovate e *:

not at all: 0.0 %
somewhat: 0.0 %
moderate: 0.0 %
high: 0.0 %
very high: 100 %

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 0.0 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 100 %

Time on Temovate e *:

Gender of people when taking Temovate e *:

female: 100 %
male: 0.0 %

Age of people when taking Temovate e *:

Conditions people have *:

Psoriasis (immune-mediated disease that affects the skin): 1 person, 100.00%

Other drugs people take besides Temovate e *:

Halog: 1 person, 100.00%
Elidel: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Temovate e and have Panic attack?

Check whether Panic attack is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Panic attack in Temovate e

How the study uses the data?

The study is based on clobetasol propionate (the active ingredients of Temovate e). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.